ripekg:evaluation/RIPEA148131811A593CED |
prov:used |
ripekg:registry-evidence/RIPEA148131811A593CED |
ripekg:registry-evidence/RIPEA148131811A593CED |
rdf:type |
rdfs:Resource |
ripekg:registry-evidence/RIPEA148131811A593CED |
rdf:type |
owl:Thing |
ripekg:registry-evidence/RIPEA148131811A593CED |
rdf:type |
ripe:IntegrityAssessmentEvidenceIntegrity assessment evidence |
ripekg:registry-evidence/RIPEA148131811A593CED |
rdf:type |
ripe:RegistryEvidenceRegistry evidence |
ripekg:registry-evidence/RIPEA148131811A593CED |
rdf:type |
tido:Evidence |
ripekg:registry-evidence/RIPEA148131811A593CED |
prov:wasAttributedTo |
ripekg:source/clinicaltrials-govClinicalTrials.gov |
ripekg:registry-evidence/RIPEA148131811A593CED |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEA148131811A593CED |
ripekg:registry-evidence/RIPEA148131811A593CED |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEA148131811A593CED |
ripekg:registry-evidence/RIPEA148131811A593CED |
ripe:concerns |
ripekg:work/10.1136%2Fbmj-2024-083382Prevention of acute myocardial infarction induced heart failure by intracoronary infusion of mesenchymal stem cells: phase 3 randomised clinical trial (PREVENT-TAHA8) |
ripekg:registry-evidence/RIPEA148131811A593CED |
ripe:concerns |
ripekg:work/10.1136%2Fbmj-2024-083382e083382 | the bmj Protected by copyright, including for uses related to text and data mining, AI training, and similar technologies |
ripekg:registry-evidence/RIPEA148131811A593CED |
ripe:isProspective |
true |
ripekg:registry-evidence/RIPEA148131811A593CED |
ripe:registrationAssessmentRationale |
Comparison performed at month level. Registration: 2021-09, LLM Recruitment Start: 2021-09. Deemed prospective at month level. |
ripekg:registry-evidence/RIPEA148131811A593CED |
ripe:registrationDate |
06-09-2021 |
ripekg:registry-evidence/RIPEA148131811A593CED |
ripe:registrationId |
NCT05043610 |
ripekg:registry-evidence/RIPEA148131811A593CED |
ripe:registrationLink |
https://clinicaltrials.gov/study/NCT05043610 |
ripekg:registry-evidence/RIPEA148131811A593CED |
ripe:registryName |
ClinicalTrials.gov |
ripekg:registry-evidence/RIPEA148131811A593CED |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEA148131811A593CED-human-2-2 |
ripekg:registry-evidence/RIPEA148131811A593CED |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEA148131811A593CED-inspectai-2-2 |